2022 annual financial data
BioNTech 2022 Operating cash flow margin
Direct answer
Operating cash flow margin was 78.43%.
Operating income was 12,642,700,000 EUR and net income was 9,434,400,000 EUR.
Operating cash flow was 13,577,400,000 EUR.
Get free BioNTech email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 17,310,600,000 EUR
- Operating income
- 12,642,700,000 EUR
- Net income
- 9,434,400,000 EUR
- Operating cash flow
- 13,577,400,000 EUR